EVH Relative Valuation
EVH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EVH is overvalued; if below, it's undervalued.
Historical Valuation
Evolent Health Inc (EVH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 26.13. The fair price of Evolent Health Inc (EVH) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：3.88
Fair
16.92
PE
1Y
3Y
5Y
Trailing
Forward
9.45
EV/EBITDA
Evolent Health Inc. (EVH) has a current EV/EBITDA of 9.45. The 5-year average EV/EBITDA is 21.22. The thresholds are as follows: Strongly Undervalued below 3.85, Undervalued between 3.85 and 12.54, Fairly Valued between 29.90 and 12.54, Overvalued between 29.90 and 38.59, and Strongly Overvalued above 38.59. The current Forward EV/EBITDA of 9.45 falls within the Undervalued range.
14.12
EV/EBIT
Evolent Health Inc. (EVH) has a current EV/EBIT of 14.12. The 5-year average EV/EBIT is 48.97. The thresholds are as follows: Strongly Undervalued below -167.47, Undervalued between -167.47 and -59.25, Fairly Valued between 157.19 and -59.25, Overvalued between 157.19 and 265.41, and Strongly Overvalued above 265.41. The current Forward EV/EBIT of 14.12 falls within the Historic Trend Line -Fairly Valued range.
0.19
PS
Evolent Health Inc. (EVH) has a current PS of 0.19. The 5-year average PS is 1.44. The thresholds are as follows: Strongly Undervalued below 0.18, Undervalued between 0.18 and 0.81, Fairly Valued between 2.07 and 0.81, Overvalued between 2.07 and 2.70, and Strongly Overvalued above 2.70. The current Forward PS of 0.19 falls within the Undervalued range.
5.60
P/OCF
Evolent Health Inc. (EVH) has a current P/OCF of 5.60. The 5-year average P/OCF is -49.21. The thresholds are as follows: Strongly Undervalued below -698.33, Undervalued between -698.33 and -373.77, Fairly Valued between 275.35 and -373.77, Overvalued between 275.35 and 599.91, and Strongly Overvalued above 599.91. The current Forward P/OCF of 5.60 falls within the Historic Trend Line -Fairly Valued range.
12.53
P/FCF
Evolent Health Inc. (EVH) has a current P/FCF of 12.53. The 5-year average P/FCF is 89.07. The thresholds are as follows: Strongly Undervalued below -367.04, Undervalued between -367.04 and -138.99, Fairly Valued between 317.13 and -138.99, Overvalued between 317.13 and 545.18, and Strongly Overvalued above 545.18. The current Forward P/FCF of 12.53 falls within the Historic Trend Line -Fairly Valued range.
Evolent Health Inc (EVH) has a current Price-to-Book (P/B) ratio of 0.52. Compared to its 3-year average P/B ratio of 2.38 , the current P/B ratio is approximately -78.23% higher. Relative to its 5-year average P/B ratio of 2.86, the current P/B ratio is about -81.91% higher. Evolent Health Inc (EVH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -0.42%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.06% , the current FCF yield is about -100.00% lower.
0.53
P/B
Median3y
2.38
Median5y
2.86
-26.58
FCF Yield
Median3y
-0.42
Median5y
-1.06
Competitors Valuation Multiple
The average P/S ratio for EVH's competitors is , providing a benchmark for relative valuation. Evolent Health Inc Corp (EVH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -22.83%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of EVH decreased by 64.36% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -3.72 to -4.35.
The secondary factor is the Revenue Growth, contributed -22.83%to the performance.
Overall, the performance of EVH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Evolent Health Inc (EVH) currently overvalued or undervalued?
What is Evolent Health Inc (EVH) fair value?
How does EVH's valuation metrics compare to the industry average?
What is the current P/B ratio for Evolent Health Inc (EVH) as of Dec 05 2025?
What is the current FCF Yield for Evolent Health Inc (EVH) as of Dec 05 2025?
What is the current Forward P/E ratio for Evolent Health Inc (EVH) as of Dec 05 2025?